APOB and atherosclerosis: Whereas, therapeutic interventions that aim to stabilize and/or expand ApoB+ Tregs hold promise for atherosclerosis prevention and treatment, immunomodulatory therapies causing destabilization of Tregs naturally aggravate progression of atherosclerotic lesions (46).